Scholars Central

Conference abstractPublished 28 Nov 2013

Coronary revascularisation in stable patients after an acute coronary syndrome: Early invasive versus conservative management

Authors: Raffaele Bugiardini

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Within the field of clinical practice, it is common knowledge that patients with acute coronary syndromes (ACS) presenting with recurrent ischaemic episodes despite aggressive medical therapy, haemodynamic instability, overt congestive heart failure or serious ventricular arrhythmias may benefit from early in-hospital coronary revascularisation. In contrast, it remains uncertain whether patients whose condition can safely be stabilised in the coronary care unit should routinely receive an interventional approach before hospital discharge. Previous studies lumped together patients with such markedly different clinical characteristics As a result, they were unable to evaluate whether patients who met stabilisation criteria also derived substantial benefit from coronary revascularisation therapy. The research question is relevant, as in a substantial number of patients control of anginal symptoms, ECG changes and haemodynamics are achieved with medical treatment within the first 24 h. The principal finding is that outcomes in the great majority of patients appear to be unaffected by treatment with in-hospital coronary intervention. The objective of our study was to formally test the impact of medical therapy versus coronary revascularisation added to medical therapy on the management of patients with recent ACS who were stable for 48 h after an ACS. In summary, we observed a strong and robust heterogeneity in the treatment effects of an invasive strategy, which was associated with a significant reduction in cardiovascular events at 6 months among patients with the oldest age, high-risk clinical features (prior myocardial infarction and renal failure) and biochemical evidence of a strong inflammatory activity (high C reactive protein levels). Conversely, a routine in-hospital elective revascularisation was not associated with reduced risk over medical therapy in the majority of patients. There was evidence of an increased hazard with an invasive strategy in younger male patients with STEMI and a family history of coronary disease. If corroborated by other studies, these findings may have profound clinical implications on the contemporary management of patients whose condition can safely be stabilised after an ACS.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Raffaele Bugiardini”